Drug use cases:
Significant response to Cytodrox has been observed in refractory, stable, and recurrent chronic myeloma and leukemia, as well as non-surgical, recurrent, and metastatic ovarian carcinoma.
Cytodrox is prescribed concomitantly with radiation therapy to regionally control squamous cell carcinoma of the head and neck, excluding the lips.
Reviews
There are no reviews yet.